Rigel Pharmaceuticals' Unattributed VC Round

Rigel Pharmaceuticals raised a round of funding on August 15, 2000.

Rigel Pharmaceuticals discovers and develops drugs for the treatment of inflammatory/ autoimmune diseases and cancer, as well as viral and metabolic diseases. Their research focuses on intracellular s…

Articles about Rigel Pharmaceuticals' Unattributed VC Round: